Clinical Trial Update: Tanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of tanespimycin in patients with inoperable locoregionally advanced or metastatic thyroid cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Thyroid Cancer
• Medullary Thyroid Carcinoma
• Papillary Thyroid Cancer
• Thyroid Cancer

Drugs mentioned

• tanespimycin (17-N-allylamino-17-demethoxygeldanamycin)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Thyroid Cancer, Stage IV Follicular Thyroid Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-05-06